Funding Details
- Awarder
- Inbox
- Date Award
- August 08, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Valuation
-
$1,000,000
Company Info
- Founding Year
- 2016
- Traction
- BlueRock Therapeutics will continue to operate as an independent company with a focus on developing cell therapies in neurology, cardiology, and immunology.
- Organizations Involved
- Bayer AG, Versant Ventures
- Company Description
- BlueRock Therapeutics is a biotechnology company focused on developing engineered cell therapies in the fields of neurology, cardiology, and immunology using a proprietary induced pluripotent stem cell (iPSC) platform. Bayer will fully acquire BlueRock Therapeutics, with an initial focus in neurology, cardiology, and immunology.
- Market
- Neurology, Cardiology, Immunology
- Location
-
Cambridge,
MA,
US
- Coinvestors
- Versant Ventures
Links